Dear Valued Customer,
Fresenius Kabi Canada is pleased to announce the launch of Caspofungin Acetate for Injection in a room-temperature stable formulation. Fresenius Kabi Caspofungin is available in two presentations: 50mg per vial and 70mg per vial.
Fresenius Kabi developed its Caspofungin to be stable at room temperature, making it the only form of Caspofungin Acetate for Injection to require no refrigeration. This can help pharmacists save on the limited refrigeration space available to them. Our Caspofungin Acetate for Injection is bar-coded, latex free, and preservative free.
This product will be available at all distribution centres effective February 3rd, 2020
If you would like to obtain more information on this product, please contact your sales representative or our Customer Service Department at (877) 821-7724.
Senior Manager – Marketing, IV Drugs